Quality of life and psychosocial well-being in thyroid eye disease in Japan: pre-teprotumumab national survey

Read full text Summarise with VIRAT
Authors: Emoto Shun, Yoshito Bushita, Toshio Nagase, Kunihiro Nishimura, Yuji Hiromatsu, Yukiko Nishimura
Cited by: 0
References: 19

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Background Thyroid eye disease (TED) causes functional and psychosocial morbidity, but little is known about the patient-experienced burden in Japan. Objective To assess health-related quality of life (QOL) and psychological well-being among TED patients using standardized quantitative instruments and discuss patient-reported outcomes of patients in Japan compared to the United States, Europe, and Asia. Methods This is the first Japanese nationwide cross-sectional survey that shows a natural history of QOL prior to the launch of teprotumumab outside of the United States. Fifty-six TED patients were recruited and answered questionnaires including the Short-Form 12-Item Survey version 2 scores (SF-12v2), Graves' Ophthalmopathy Quality of Life Questionnaire (GO-QOL), Hospital Anxiety Depression Scale, and Client Satisfaction Questionnaire 8. Disease activity and severity were classified based on European Group on Graves' Orbitopathy criteria. Results While the SF-12v2 physical component summary and mental component summary scores were similar to population norms, SF-12v2 role component summary scores (mean = 39.5) were notably below the national normal. GO-QOL appearance-related/psychosocial scores were impaired as well as SF-12v2 and were particularly lower in active disease (52.5 vs 73.3; P = .004). The presence of symptoms such as pain with eye movement, eyelid swelling, strabismus, upper eyelid retraction, and proptosis was significantly associated with lower role/social functioning and satisfaction with care. Conclusion TED imposes a significant psychosocial burden, particularly in active disease and among those with symptoms involving structure changes. Psychosocial support and targeted symptom control may improve patient-centered outcomes in TED.

Fields of Study & Subjects

Ophthalmology and Eye Disorders Ocular Disorders and Treatments Myasthenia Gravis and Thymoma

Publication details

Journal / source
Journal of the Endocrine Society
Volume
10
Issue
7
Pages
bvag069–bvag069
Publication date
25 March 2026
Language
EN